<DOC>
	<DOCNO>NCT02097485</DOCNO>
	<brief_summary>The purpose study evaluate ovicidal efficacy single application abametapir lotion 0.74 % w/w intend treatment head louse .</brief_summary>
	<brief_title>Ovicidal Efficacy Safety Abametapir Lotion 0.74 % Administered Treatment Head Lice Infestation</brief_title>
	<detailed_description />
	<mesh_term>Lice Infestations</mesh_term>
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Mite Infestations</mesh_term>
	<criteria>1 . Healthy male female base medical history 2 . Six month age old . 3 . Has active head louse infestation minimum 3 live head louse least 10 undamaged unhatched head louse egg hair . 4 . Agrees examination head louse compliance study procedure . 5 . All adult subject must sign write voluntary informed consent . For minor , parent/ legal guardian agree subject participate study determine sign assent inform consent . 1 . Has scalp disease history allergies prior reaction head louse product . 2 . Has condition , opinion Investigator , may interfere study . 3 . Is receive systemic topical medication , opinion Investigator , may compromise integrity safety and/or efficacy assessment . 4 . Had treatment ( overthecounter ( OTC ) home remedy medication ) head louse within 14 day prior Day 0 . 5 . Has receive investigational agent within 30 day prior Day 0 .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>